KALA BIO, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
KALA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1167 Massachusetts Avenue, Arlington, MA

Insiders trading volume in the past year

KALA BIO, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rajeev M. Shah Director $73.6M Jun 17, 2021
Ra Capital Management, L.P. 10%+ Owner $47.4M May 26, 2022
Gregory Grunberg Director $36.7M Jun 17, 2021
Baker Bros. Advisors Lp 10%+ Owner $3.82M Jun 28, 2024
Hongming Chen Chief Scientific Officer $1.38M Oct 26, 2021
Mark T. Iwicki CHIEF EXECUTIVE OFFICER, Director $1.25M -$148K -10.5% Jun 26, 2024
Eric Trachtenberg Chief Legal Officer, Chief Compliance Officer and Secretary $459K -$8.27K -1.77% Jan 4, 2024
Romulus K. Brazzell Head of Research and Development and Chief Medical Officer $399K -$49.2K -11% Jun 26, 2024
Todd Bazemore President and Chief Operating Officer $394K -$44.3K -10.1% Jun 26, 2024
Mary Reumuth Chief Financial Officer $286K -$38.9K -12% Jun 26, 2024
Darius Kharabi Chief Business Officer $284K -$35.2K -11% Jun 26, 2024
Mark S. Blumenkranz Director $87.5K Jun 11, 2024
Howard B. Rosen Director $85.6K Jun 11, 2024
Andrew I. Koven Director $84.8K Jun 11, 2024
Gregory D. Perry Director $66.3K Jun 11, 2024
C. Daniel Myers Director $48.3K Jun 11, 2024
Marjan Farid Director $47.5K Jun 11, 2024
Robert Bradley Paull Director Jun 16, 2022

Recent Insider Transactions by Companies or Individuals for KALA BIO, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.